To compare the gene expression profiling between intestinal-type gastric cancer (IGC) and diffuse-type gastric cancer (DGC), cDNA microarray containing 7334 gene elements was performed on 12 paired IGC specimens/its' normal epithelial tissue and 11 paired DGC specimens/its' normal epithelial tissue. Twenty-seven genes were co-overexpressed in IGC and DGC. These overexpressed genes were related to transcription and translation, DNA replications and mitosis, calcium binding, apoptosis and mitochondria protein.
Introduction
Gastric cancer is the second most frequent cause of cancerrelated death in the world after lung cancer (1) . According to Lauren's classification, gastric cancer can be divided into two histologically distinct types, each of which accounts for half of the cases: IGC and DGC (2) . IGC, the predominant type of tumor in high-risk areas, has a glandular pattern and is usually accompanied by papillary formation or solid components (2) . DGC, in contrast, consists of poorly cohesive cells diffusely infiltrating the gastric wall with little or no gland formation (2) . A special subgroup of this type is the so-called signet ring cell carcinoma, in which the cell nucleus is pushed against the cell membrane creating a classical signet appearance due to an expanded, globoid, optically clear cytoplasm. IGC and DGC may result from the transformation of different epithelial cells or distinct molecular changes in a common cell type (3) .
Over the past decade, many studies have clearly demonstrated that the combination of molecular changes differs between IGC and DGC, suggesting that they have unique genetic alterations (4) (5) (6) . Alterations in specific genes that play important roles in diverse cellular functions, such as cell adhesion, signal transduction, differentiation, development or DNA repair, have been identified (7, 8) . With regard to genetic alterations in so-called tumor suppressor genes or oncogenes, gastric cancer is no exception. Inactivation due to loss of heterozygosity (LOH) and or mutation of p53, APC and DCC have been reported in gastric cancer. Mutation of p53 was detected in about 30% of gastric cancers independent of the histological subtype (9, 10) . Up to 60% of the IGC but 30% of DGC have mutation/LOH of the APC gene (11) . DCC LOH have been detected in 50% of IGC whereas, in DGC, this LOH is absent (12) . The met proto-oncogene codes for the hepatocyte growth factor receptor which is preferentially amplified and overexpressed in DGC (13) . Other growth factor and receptor signal systems that may be altered include EGFR, TGF-· and K-sam (14) . Adhesion molecules, such as ß-catenin, have been detected in 30% mutation of IGC but are absent in DGC (15) . E-cadherin is the binding partner of ß-catenin and plays a crucial role in establishing the structural integrity of epithelial tissue. E-cadherin mutations have been detected in 50% of DGC but are absent in IGC (16) .
Because the development and progression of gastric cancer is a very complicated process, we hypothesized that many other genes are as yet undiscovered. However, identifying these genes by conventional methods, such as Northern blots, and serial analysis of gene expression has been either labor intensive or non-systematic. High throughput methods, such as cDNA and oligonucleotide microarrays, are increasingly being used to systematically compare molecular features of individual cancers to key clinical parameters (17) (18) (19) (20) . Previous expression profiling studies of gastric cancer highlighted differences in gene expression between tumors and adjacent mucosa but failed to identify gene expression patterns discriminating histological subtypes (21) . Our study uses 12 pairs of IGC and 11 pairs of DGC specimens to view whether the genetic alterations are different between the two types of gastric cancer.
Materials and methods
Patients and specimens. Tumor and normal specimens were collected from patients with GC requiring subtotal or total gastroectomy resection in Chang Gung Memorial Hospital (CGMH) in Taiwan. Written informed consent was obtained before collection and this study was approved by the IRB. Table I summarizes the characteristics of patient samples. Each pair of normal samples were isolated. Tumors were resected and divided (fresh frozen in -80˚C freezer and formalin-fixed) within 15 min ex vivo. Formalin-fixed tissue sections were stained with H&E and classified by a pathologist. These results were compared with the pathology records from CGMH. The final pathology was determined by consensus and review if necessary. Each specimen was attributed a diagnosis and scored for Lauren's classification. Pathological AJCC stages were obtained from clinical records with patient permission. H. pylori serological testing was performed using PANBIO H. pylori IgG ELISA on preoperative serum collected on patients.
Microarray analysis. Total RNA was isolated by phenolchloroform extraction (TRIzol; Invitrogen) and column chromatography (RNeasy; Qiagen). The total RNA was then qualified and quantified by RNA LabChip on Bioanalyzer 2100B (Agilent). Total RNA (10 μg) was labeled using reverse transcription with Superscript II (Invitrogen) and Cy5-dCTP (Amersham) for tumor specimens and with Cy3-dCTP (Amersham) for normal specimens. The procedure was similar to previous methods (22) . Labeled cDNA was cohybridized in 1X hybridization buffer (Amersham) and 50% formamide for 14-16 h at 42˚C to spotted cDNA arrays printed at the CGMH Microarray Core Facility. These comprised 7344 elements representing 6394 unique cDNAs (Unigene Cluster) and were printed onto an aminosilane-coated slide (ArrayIt) using a robotic arrayer (Genetix). Slides were washed in 1X SSC with 0.2% SDS, then 0.1X SSC, and finally 0.1X SSC at room temperature and scanned using a confocal scanner ChipReader (Virtek). Data were managed using MATLAB 6.0 software (The MathWorks).
Quantitative PCR. Four representative genes (claudin 4, annexin A1, CCL7 and CCL8) were selected that were differentially expressed, based on hierarchical clustering of gene expression signatures. Reverse transcription was performed on RNA samples using random hexamers (Gibco BRL) as primers and superscript reverse transcriptase (Gibco BRL), as described in the instruction manual provided by the manufacturer. The cDNA amplification was performed using an ABI PRISM 7700 sequence detection system, using the 5' nuclease method (TaqMan) with a two-step PCR protocol (95˚C for 10 min followed by 40 cycles of 95˚C for 15 sec and 60˚C for 1 min). All primers and probes were purchased from ABI. The lot numbers of claudin 4, annexin A1, CCL7, and CCL8 were Hs00533616-S1, Hs00167549-m1, Hs00171147-m1 and Hs00428422-q1, respectively. The number of PCR cycles required for the detection of each transcript was defined (cycle threshold: CÙ). Serial dilutions of a standard cDNA were included to ensure linearity and reproducibility of the assay. The quantitative value of each sample was calculated as the ratio between the amount of the test gene and the endogenous control of the house-keeping gene, GAPDH.
Immunohistochemistry. The tissue block were constructed according to the method of Schraml et al (23) and the best representative morphological areas of tumors were used in this study. The specimen sections were deparaffinized, then blocked endogenous peroxidase with 3% hydrogen peroxide and microwaved after pretreatment in citric acid to retrieve antigenicity. The sections were incubated with blocking solution containing PBS and 1% bovine serum albumin for 20 min at room temperature, and then incubated with primary antibody (goat anti-human polyclonal antibody from Santa Cruz Biotechnology) overnight at 4˚C. After washing 4 times with TBS, the sections were incubated with secondary antibody (rabbit anti-goat IgG, Santa Cruz Biotechnology). The immuno-complex was visualized by the immunoglobulin enzyme bridge technique using the Dako LSAB 2 System, HRP kit (Dako Corp. Carpinteria, CA) with 3,3' diamino- Table I . Clinical and pathological parameters of patient samples included for microarray analysis Lymph node status N0 Table II . Genes significantly co-overexpressed in IGC and DGC. Data analysis. Data were imported into GeneSpring (Silicon Genetics) and intensity-dependent normalization carried out using LOWESS. A group of 7344 elements satisfied filtering criteria based on the presence of a significant signal in ≥80% of hybridizations. Hierarchical clustering was performed using Pearson correlation as a measure of similarity, after average linkage and median centering of values using the program, Cluster, and viewed with Treeview. Discriminant genes and differences between the two groups were analyzed using twotailed ANOVA with Benjamini Hochberg multiple testing correction factor at P≤0.05.
Results
Co-overexpressed and co-underexpressed gene expression in IGC and DGC. We compared the gene expression of IGC and DGC with that of normal stomach tissue using a cDNA microarray containing 7344 gene elements. To identify genes that exhibited the most significant and consistent expression changes in IGC and DGC compared with normal stomach tissue, we analyzed the gene expression ratios as described in Materials and methods. We first selected outlying genes that have an average expression ratio >2.0 SD from the mean. This 2.0 SD cut-off represents a 95% confidence interval. There were a total of 39 genes that met these analysis criteria for co-overexpression and co-underexpression (27 for overexpressed and 12 for underexpressed). They accounted for 0.53% of the 7344 unique cDNA clones included in the microarray.
The co-overexpressed genes are listed in Table II and counderexpressed genes are listed in Table III . The 27 genes whose expressions were co-overexpressed in IGC and DGC represented a variety of functional groups. There are seven genes involved in transcription and translation; XBP (a transcription factor recognizing both the X2 promoter element of both the human DR-· and DP-ß) (25) , SKP1A (involved in transcription regulation for the development or maintenance of specialized functions of the inner ear) (26) , NCOA1 (steroid receptor coactivator-1, a coactivator that is required for full transcriptional activity of the steroid receptor superfamily) (27) , ATF-4 (cAMP-dependent transcription factor-4) (28,29), ZFP36 (an unusual zinc finger structure) (30) , POU2F2 (an octamer-binding transcription factor) (31) and YARS (catalyze the aminoacylation of tRNA by their cognate amino acid) (32) . PCTK1 (serine/threonine-specific protein kinase regulating the initiation and passage through mitosis) (33) is involved in DNA replications and mitosis and S100 (regulating sarcoplasmic reticulum calcium ion handling and myofibrillar calcium ion responsiveness) (34) is involved in calcium binding. TEGT (a BAX inhibitor) (35) is associated with apoptosis and three genes are mitochondria protein: MTCO4, ATP synthase and CKMT2. There are ten genes which function as enzymes and four genes listed under 'others' (Table II) . The 12 genes who were co-underexpressed in IGC and DGC represented a variety of functional groups (Table III) . ITGB1 (36) and fibronectin (37) are involved in cell adhesion and migration. The functions of KIF2C (38) and CFL1 (39) are associated with organelle movement and intracellular transport. Two genes, TUBA6 and TUBB5, are involved in the cytoskeleton.
Differential gene expression profiling between IGC and DGC.
A clustering dendrogram of IGC and DGC with 27 genes significantly differs between IGC and DGC. The upper 19 genes were more overexpressed in DGC than in IGC. These genes included ANXA1, CCL7 and CCL8. The bottom 8 genes were more overexpressed in IGC than in DGC. These genes included CLDN4 and CCT3 (Fig. 1) . 
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hemopoiesis and immunological reactions -----------------------------------------------------------------------------------------------------
Confirmation of microarray results with quantitative real-time PCR.
To validate our RNA expression results, we selected four genes, CLDN4, ANXA1, CCL7 and CCL8, conducted on 3 IGC and 2 DGC samples to perform quantitative real-time PCR as an assessment of relative RNA abundance. Table IV shows that there was an excellent concordance of the results of quantative real-time PCR analysis and microarray finding.
Immunohistochemical analysis of protein expression. We selected four differentially expressed genes between IGC and DGC to compare their transcript and protein expression.
Three of these genes, ANXA1, CCL7 and CCL8, were overexpressed in DGC compared with in IGC. CLDN4 was overexpressed in IGC compared with in DGC. Immunohistochemical staining of IGC and DGC tissue sections with the four antibodies confirmed the pattern of expression seen in our microarray experiments (Fig. 2) .
Discussion
In the present study, we used cDNA microarray to explore the variations in gene expression between IGC and DGC. ONCOLOGY REPORTS 15: 57-64, 2006 Table III. Genes significantly co-underexpressed in the IGC and DGC. 
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Twenty-seven genes were identified as significantly co-overexpressed in IGC and DGC. These genes can be categorized into several groups on the basis of their known functions (Table II) . The first major group of genes was transcription or translated genes and included transcriptional factors such as X-box binding protein (XBP); activating transcription factor 4 (ATF-4); and POU domain, class 2, transcriptional factor 2 (POU2F2); and transcriptional or translational machineryrelated genes. The overexpression of these genes was not mentioned in gastric cancer progression although they are involved in the regulation of cell growth and proliferation.
DNA replications and mitosis-related genes were another important group of genes overexpressed in gastric cancer, including PCTK1. One calcium binding protein, S100 and one anti-apoptotic protein, TEGT were also highly expressed in gastric cancer. Three mitochondria proteins involved in the respiratory complex and ten enzymes with various catalytic functions were overexpressed in gastric cancer (Table II) .
Twelve genes were identified as significantly co-underexpressed in IGC and DGC. These genes can be categorized into several groups on the basis of their known functions (Table III) . Cell adhesion and migration-related genes were the major group of genes underexpressed in gastric cancer. This group included integrin, ß1; and fibronectin. Bittner et al also showed that the expression of integrin, ß1 was reduced in gene expression profiling of cutaneous malignant melanomas (40) . Fibronectin is an extracellular glycoprotein that serves as a ligand for the integrin family of cell adhesion receptors and regulates cytoskeletal organization. Fibronectin expression has been linked with tumorigenesis (41) and metastasis (42) , although these studies were only correlative. Peptides that mimic the cell adhesive region of fibronectin were, however, known to inhibit metastasis (43) , which may indicate that tumor cells must interact with molecules such as fibronectin to metastasize. Another group consisted of organelle movement and intracellular transport genes, including KIF2C and CFL1. The reasons for the down-regulation in expression of these two genes involved in gastric cancer progression was unknown. Recent reports showed that KIF2C was a microtubule depolymerase that forms an ATP-hydrolyzing complex at microtubule ends (38) but CFL1 promoted actin polymerization and defined the direction of cell motility (39) . The down-regulation in expression of the cytoskeleton-related genes, tubulin ·6 and tubulin ß5, was unexpected because tubulin was a chemotherapeutic target. The taxanes, paclitaxel and docetaxel, which act on microtubules to arrest mitosis, were the best antineoplastic drugs against a wide spectrum of cancers, including ovarian cancer, breast cancer, small and non-small cell lung cancer, colon cancer, head and neck cancer, multiple myeloma, melanoma, and Kaposi's sarcoma (44) . The identification of down-regulated expression in MMP-2 and MMP-10 was unexpected because one would expect the MMP genes to be overexpressed in tumor cells, especially in metastastic tumor cells (45) .
The expression of the adherens junction varies with the disruption of glandular morphology and loss of differentiation. It has been suggested that the loss of tight junction function is related to tumor differentiation and our results showed that claudin 4 was down-regulated in DGC. Lee et al also showed that the reduced expression of claudin 4 was more frequent in DGC than in IGC and the reduced expression of claudin 4 correlated with poor differentiation (46) .
Our results showed that annexin A1 was down-regulated more frequently in IGC than in DGC. Annexin A1 belongs to a family of Ca(2+)-dependent phospholipid binding proteins which have a molecular weight of approximately 35000-40000 and are preferentially located on the cytosolic face of the plasma membrane. Annexin A1 protein had an apparent relative molecular mass of 40 kDa, with phospholipase A2 inhibitory activity. Hu et al showed that allelic loss of annexin A1 occured frequently, whereas somatic mutations were rare, suggesting that annexin A1 was not inactivated in esophageal squamous cell carcinoma via a two-hit mechanism (47) . A decrease in annexin A1 protein expression was confirmed, consistent with a quantitative decrease in mRNA expression, and appeared to be related to tumor cell differentiation. Hu et al concluded that annexin A1 was not the tumor suppressor gene corresponding to the high levels of loss of heterozygosity observed on chromosome 9 in esophageal squamous cell carcinoma; however, dysregulation of mRNA and protein levels was associated with esophageal squamous cell carcinoma (47) .
The CCL7 and CCL8 chemokines subdivided into C-C chemokines having 2 adjacent cysteine residues. C-C chemokines predominantly attract monocytes/macrophages and have been involved in macrophage recruitment during inflammation and cancer invasion. These factors are often produced by invasive cancer cells (48) . This is consistent with our results that CCL7 and CCL8 were more overexpressed in DGC than in IGC.
Many studies in the past decade have clearly demonstrated that multiple genetic alterations are responsible for the development and progression of gastric cancer. Alterations in specific genes that play important roles in diverse cellular functions such as cell adhesion, signal transduction, transcription and translation, DNA replication and mitosis, and DNA repair have been identified. With regard to genetic alterations in so-called tumor suppressor genes or oncogenes, gastric cancer is no exception. Such tumor-associated gene alterations have frequently been reported in both histological subtypes of gastric cancer. However, the combination of molecular changes differs between IGC and DGC, suggesting that they may have unique genetic pathways and our microarray results support this hypothesis. Table IV . Quantitative real-time PCR values and cDNA ratios for representative genes.
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